Cellestis launches online service for new blood test for TB
3 July 2007
Australian medical diagnostics company Cellestis has
created a website to provide worldwide information on the availability of
its QFT test for TB.
Cellestis claims that QFT is the only blood test for
the detection of TB infection that is approved in most developed and EU
nations, including the USA, Japan, France, UK, Czech Republic, Switzerland
It is approved for sale in the European Union, and available
in many other countries. It is also recommended by national testing
guidelines in many nations, including the USA, UK, France and Japan.
widespread use of QuantiFERON-TB Gold, along with the many national
guidelines from most major countries indicating its advantages, makes it a
consistent international standard," said Dr Tony Radford, CEO of Cellestis.
"A QFT test gives the same accurate result worldwide, regardless of where
or by whom the test is run, whereas skin testing results vary enormously due
to differences in reagents, doses, test-cut-offs and interpretation. This
makes QFT an attractive product for controlling TB internationally, and for
testing those whose work or travel takes them cross international borders"